Lixiana OD tablets 60mg, manufactured by Daiichi Sankyo, contain edoxaban tosilate hydrate, an oral anticoagulant that prevents blood clots by inhibiting activated blood coagulation factor X. It is used to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and to treat and prevent deep vein thrombosis and pulmonary embolism. The YJ code is 3339002F6021, and the standard is 60mg 1 tablet.
Lixiana OD tablets 60mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →